In advanced cirrhosis, these effects may accumulate unpredictably or trigger dangerous blood sugar swings, making standard dosing potentially hazardous without close medical oversight
Eligibility criteria typically include BMI thresholds (most commonly 27+ with comorbidities or 30+ without), age (usually 18+), and absence of contraindications (pregnancy, certain cancer histories, severe GI disease)
But popularity and market size are not evidence of efficacy
4 Efforts to extend the life of native GLP-1 led to the development of human GLP-1 analogs liraglutide, albiglutide, dulaglutide, and semaglutide
("Stem cells are the new multivitamin," said their founder, Christian Drapeau.) Many of the attendees I talked to seemed genuinely intrigued by all this stuffand invigorated by their promise
Combined treatment with high-dose ACEI and sitagliptin significantly increased BP by elevating the expression of substance P, while low-dose ACEI had no such effect (22)